π Medicine Name:
Daunorubicin
π Formulation:
Injection β for intravenous (IV) use only
πͺ Strength:
5 mg/mL
(Usually provided in multi-dose or single-dose vials, depending on the manufacturer)
π Description:
Daunorubicin is an anthracycline antibiotic chemotherapy drug, used mainly in the treatment of hematologic cancers, particularly various forms of leukemia. It is cytotoxic, disrupting cancer cell growth and survival by damaging DNA.
πΏ Nature:
- Cytotoxic antitumor antibiotic (anthracycline class)
- Cell cycleβnon-specific, but most active in rapidly dividing cells
- Deep red-colored solution (“red devil” nickname in clinical settings)
- High-risk vesicant β extravasation can cause severe tissue damage
- Requires careful handling and central IV administration
π Advantages:
- Highly effective in treating acute leukemias like AML and ALL, especially when combined with other agents (e.g., cytarabine)
- Central to induction chemotherapy protocols in pediatric and adult patients
- 5 mg/mL concentration allows for accurate dosing in variable patient weights
- Long track record of clinical use with well-established protocols
- Available in both conventional and liposomal forms (liposomal form used in some relapsed/refractory settings)
- Typically used in curative intent regimens
π§Ύ Prescription:
- Prescription-only (Rx)
- To be administered only in specialist oncology centers under supervision of trained professionals
π― Indications / Uses:
- Acute myeloid leukemia (AML) β in adults and children
- Acute lymphoblastic leukemia (ALL)
- Sometimes used in Kaposi’s sarcoma (off-label, HIV-associated cases)
- Used in induction and consolidation phases of leukemia treatment protocols
π¦ Packaging:
- Supplied in glass vials as a sterile solution for injection
- Usually preservative-free, requiring use within a short time after opening
- Labeled with cytotoxic handling precautions
π§ Storage:
- Store at 2Β°C to 8Β°C (refrigerated)
- Protect from light and freezing
- Use reconstituted/diluted solution within specified time as per label
- Follow strict disposal protocols for cytotoxic waste
π¨ββοΈ Patient Advice:
- Administered only in hospitals with chemotherapy expertise
- Can cause hair loss, nausea, and low blood counts β regular monitoring is essential
- Report chest pain, breathlessness, or swelling to your doctor immediately
- Heart function may be monitored (e.g., via ECHO) before and during treatment
- Avoid vaccinations during therapy without medical advice

